Schizophrenia John M. Kane, M.D. and S. Charles Schulz, M.D. Establish treatment goals for patients presenting with first-episode schizophrenia. Recognize the role of genetics in determining response to antipsychotic medication in patients with schizophrenia. Utilize strategies that increase the likelihood of adherence to prescribed treatment and prevent relapse in patients with schizophrenia. Identify patients who may benefit from clozapine based on new criteria for nonresponse. Consider augmentative treatment for patients with schizophrenia within the context of evidence from the Cochrane review.
Pain Management Daniel J. Clauw, M.D. and Barry Eliot Cole, M.D. Appreciate pathophysiologic distinctions between acute and chronic pain. Identify factors that predispose patients to developing chronic widespread pain and central pain. Restore proper modulation of nociceptive signaling to relieve pain in patients with central pain. Explain pain-reducing mechanisms associated with different psychotropic adjuvants for pain. Provide adjuvants to relieve pain in treatment-resistant patients.
Complementary and Alternative Medicine Marlene P. Freeman, M.D. and George T. Grossberg, M.D. Cite forms of CAM supported by high-quality clinical evidence. Recommend forms of CAM that have been shown to be effective in improving psychiatric symptoms. Identify patients most likely to benefit from additional intake of omega-3 fatty acids. Recognize potential consequences of herbal medications unique to elderly patients. Avoid potential toxicities and interactions associated with popular herbal medications.
Attention-Deficit/Hyperactivity Disorder John R.D. Bell, M.D. Apply diagnostic criteria to identify children with ADHD. Recognize characteristics and traits commonly seen in children with ADHD. Identify comorbidities commonly associated with ADHD. Prescribe medications to treat and manage symptoms of ADHD. Avoid side effects and complications associated with medications used to treat ADHD.
Neuroscience of Addiction Stanley D. Glick, M.D., Ph.D. Identify brain structures, processes, and chemicals universally implicated in addiction. Distinguish between psychologic dependence, physiologic dependence, and addiction. Assess patients for both tolerance and sensitization to the effects of addictive substances. Recognize common triggers of cravings and relapses in patients recovering from addiction. Describe mechanisms of action responsible for mediating the neuropsychiatric and toxic effects of addictive substances.
Inflammation and Mood Disorders/Pharmacogenetics Charles L. Raison, M.D. and David A. Mrazek, M.D. Describe the relationship between biologic pathways related to stress and the etiology of depression. Recognize biologic traits associated with depression. Improve responses to antidepressants through the treatment of inflammation. Prevent side effects associated with poor metabolism of psychotropic medications. Identify patients unlikely to benefit from specific medications due to genetic polymorphisms.
Anxiety Manuel E. Tancer, M.D. and Susan M. Maixner, M.D. Distinguish normal worry from anxiety disorders that significantly impair health and quality of life. Recognize underlying social phobias in patients presenting with depression or other related psychiatric issues. Provide medication and psychotherapy to successfully treat varying forms of anxiety. Diagnose comorbidities commonly associated with anxiety disorders in older patients.
Migraine Robert B. Shulman, M.D. and Roger K. Cady, M.D. Identify etiologic factors shared among mood disorders, migraines, and chronic pain disorder. Distinguish patients with depressive traits due to bipolar disorder from those with unipolar depression. Explain mechanisms responsible for analgesic effects associated with multiple classes of psychiatric medications. Recognize neurologic traits that predispose patients to the development of migraine headaches. Educate patients about risk factors and protective influences that may affect the likelihood of a migraine attack.
Attachment Martha Farrell Erickson, Ph.D. Identify conditions necessary for the development of secure attachment. Assess the quality of attachment between a parent and child. Cite protective benefits associated with secure attachment. Recognize specific forms of insecure attachment. Provide parents with sources of formal and informal support that promote secure attachment.
Addiction and Cognitive Impairment Douglas J. Warn, L.C.S.W.–R., M.S.Ed. Identify critical areas of cognition frequently impaired in patients receiving treatment for substance abuse. Recognize neurologic and cognitive effects associated with the abuse of specific substances. Apply sophisticated screening tools to accurately assess neurocognitive deficits. Incorporate occupational therapy and cognitive remediation into treatment plans for patients with cognitive deficits and impairments. Adjust therapeutic modalities to improve efficacy in patients who have difficulties with cognition or comprehension.
Possible Additional Course Available
If you have taken the current course listed here or if you need additional Psychiatry credits, please call 800-446-5599 and ask about new courses in stock that are not listed on the website.
Here is what our clients are saying about American Seminar Institute's CME seminars...
"My husband and I have been taking your Psychiatric Review seminars for years and greatly appreciate the ease and flexibility of your program."Phyllis,MD,Montgomery, AL
"This was an excellent way to obtain my CME. I plan to take another seminar later this year!"Justin, MD, San Clemente,CA
"ASI's CME Review in Psychiatry was an excellent learning experience all around..I will be sending my colleagues your way."Shad,MD,Falls Church,VA
